Not for human consumption
The clinic provides pharmaceutical-grade peptides sourced from licensed U.S
ELIQUIS (apixaban) is a prescription medicine used in children from birth and older to treat blood clots in the veins of legs and lungs (venous thromboembolism) after at least 5 days of initial anticoagulant treatment, and to reduce the risk of them happening again
10.3389/fimmu.2018.02069 42 ToK.CaoR.YegiazaryanA.OwensJ.NguyenT.SasaniniaK.et al (2021)
Ok, so these are interesting points but please add this into the mix for future answers: The NICE Guideline clearly states that there is insufficient research why some people need more frequent injections than others and that an 8- or 12- weekly schedule does not work for everyone and some may need more frequently
For statistical analysis, continuous data were summarized as means SD or medians with IQR, contingent on data distribution, and compared using appropriate tests such as the Student t-test or Wilcoxon Rank Sum test